2022 presentations - Practical Recommendations in Immuno and Molecular Oncology (PRIMO)

2022 Presentations

Thursday, February 17, 2022
Hematologic Malignancies – Julie Vose / Sagar Lonial
Update on Novel Therapies for Non-Hodgkin Lymphoma
Relapsed and Refractory Multiple Myeloma: Choosing the Right Treatment
Sequencing of Therapies for Chronic Lymphocytic Leukemia
Acute Myelogenous Leukemia: Treatment Options
Multidisciplinary Oncology Team – Jorge J. Garcia
Physician Assistant Presentation: Immunotherapy Side Effects Management
Pharmacist Presentation: Biosimilars in Hematology Oncology: Breaking Barriers
Nurse Practitioner Presentation: Management of Patients at Risk for Hereditary Cancers
Gastrointestinal Malignancies – Rachna T. Shroff
Changing the Landscape in Pancreatic/Biliary Cancers
The Targeted and Immunotherapy Revolution in Upper GI Malignancies
Friday, February 18, 2022
Melanoma and Skin Cancers – Sanjiv Agarwala / Shane Morita
Advanced Melanoma: Making Sense of the Data
Recent Advances and Historical Perspectives in Soft Tissue Sarcoma
Genitourinary Cancer – Sanjiv Agarwala
Immunotherapy in Bladder Cancer – Current Status
Current Update on Systemic Therapy for Advanced Prostate Cancer
Special Lecture – Neoadjuvant Therapy – Sanjiv Agarwala
Neoadjuvant Therapy as a Paradigm Change for Cancer Treatment
Lung/Head and Neck Cancer – Luis E. Raez
Debate: Choosing Front Line Therapy for Non-Actionable NSCLC
Chemo/Immunotherapy Combinations
Immunotherapy alone or IO-IO combinations
Updates on Targeted Therapy NSCLC (EGFR, ALK, ROS, RET and KRASg12c)
Immunotherapy for Head and Neck Cancer
Saturday, February 19, 2022

Tumor Board – Hope S. Rugo
Breast Tumor Board Session –join forces with our breast KOLs and participate in an active discussion on the most interesting breast cases.
2 Case Reviews
Breast Cancer – Hope S. Rugo
Genomics for Early Stage Breast Cancer: Are Numbers the Key?
New Directions for TNBC: Immunotherapy and Beyond
Many Flavors: New Direction in the Treatment of HER2+ Breast Cancer
Expanding Treatment Options for HR+ Breast Cancer
Other Women’s Cancers – Hope S. Rugo
Therapeutic Advances and Areas of Active Discovery in the Cervical Cancer Space
Advances and Updates in the Treatment of Ovarian Cancer
Complications of Anticancer Therapy: from the Genitourinary Symptoms of Menopause to Sexual Dysfunction